THRD - Margin dodolan resik Third Harmonic Bio, Inc

Lambang korporat lan logo Third Harmonic Bio Inc. (THRD)

The growth of Third Harmonic Bio (THRD) share prices depends on the outcomes of Phase 2 trials of its KIT inhibitor for urticaria. The net profit margin trend demonstrates current operational efficiency, where this metric equals 0.00. The strategy is based on partnerships with scientific centers to develop immune-related drugs. However, the high concentration of resources on a single oral product creates specific binary risks for investors.

Tingkat bathi resik Third Harmonic Bio Inc (THRD): kanggo periode 28.04.2023 - 16.08.2025

Third Harmonic Bio, Inc (THRD) - rincian metrik lan laporan keuangan

- rega saham lan prakiraan rega para ahli:
Ringkesan analitik perusahaan:thirdharmonicbio.com - THRD
Produk dadi Third Harmonic Bio Inc.

The planned capacity utilization of Third Harmonic Bio (THRD) research and development complexes ensures the stable synthesis of molecules for current trial phases. By analyzing the net margin within revenue, an investor determines the portion of profit remaining after covering all operating and tax expenses. This indicator transforms price noise into a clear signal of the business's fundamental efficiency. Positive dynamics in this metric confirm the optimization of costs for certified capacities. Increasing profitability minimizes the risk of a share price drawdown, strengthening the issuer's market resilience.

Analisis pesaing

argenx (ARGX) - Margin resik|BNTX - Margin dodolan perusahaan|ABVX (Abivax Pharma) - Margin dodolan resik|Rentabilitas dodolan miturut bathi resik ADMA Bio (ADMA)|Rentabilitas dodolan miturut bathi resik PTGX (Protagonist Therapeutics Inc)|Margin dodolan resik immunovant.com (IMVT)|Margin resik kiniksa.com KNSA|Grifols SA (GRFS) - Margin resik|Adaptive Biotechnologies Inc. - Margin dodolan resik|Margin resik Celldex Therapeutics|AUPH: Margin dodolan resik|BCRX - Margin dodolan perusahaan|VERA (Vera Corp) - Margin dodolan resik|Dianthus Pharma (DNTH) - Margin dodolan perusahaan|Margin resik Pharvaris Pharma (PHVS)|Margin dodolan resik AbCellera Corp (ABCL)|Margin dodolan resik TRML (Tourmaline Bio Inc)|Margin dodolan perusahaan precigen.com (PGEN)|PHAR - Margin resik|Tingkat bathi resik NKTR (Nektar Therapeutics Inc.)|UPB (Upstream Bio Corp) - Rentabilitas dodolan miturut bathi resik|Zenas Corp (ZBIO) - Margin dodolan resik|Rentabilitas dodolan miturut bathi resik IMNM|GOSS: Tingkat bathi resik|Margin resik KalVista Pharma (KALV)|SEPN - Margin resik|Margin dodolan resik PVLA (pieris.com)|Margin dodolan resik Savara Pharma SVRA|RIGL: Rentabilitas dodolan miturut bathi resik|ANAB - Margin dodolan resik|ATXS: Margin dodolan resik|ENGN - Margin dodolan perusahaan|Rentabilitas dodolan miturut bathi resik RAPT|JBIO (Aerovate Therapeutics Inc) - Rentabilitas resik perusahaan|Margin dodolan resik ACRS|Rentabilitas dodolan miturut bathi resik kyvernatx.com KYTX|Margin dodolan resik TLSA (Tiziana Life Sciences, Ltd.)|Margin dodolan resik Cabaletta Bio CABA|VTYX: Rentabilitas dodolan miturut bathi resik|Theratechnologies Inc. (THTX) - Rentabilitas dodolan miturut bathi resik|AVTX: Margin dodolan resik|ELDN - Margin dodolan perusahaan|AGEN (Agenus, Inc) - Margin dodolan resik|Margin dodolan resik Climb Bio, Inc.|Margin resik Zura Bio Limited (ZURA)|ATYR (aTyr Pharmaceuticals) - Tingkat bathi resik|Margin dodolan resik ADAG (Adagene Inc)|IMA - Rentabilitas dodolan miturut bathi resik|STTK - Margin resik|EQ (equilliumbio.com) - Rentabilitas dodolan resik|CNTB: Margin dodolan resik|Immunic Inc (IMUX) - Margin dodolan resik|ATRA (Atara Biotherapeutics Inc) - Margin dodolan resik|Rentabilitas dodolan resik IFRX (InflaRx N.V.)|x4pharma.com (XFOR) - Tingkat bathi resik|Adicet Bio, Inc. - Rentabilitas dodolan resik|Celularity Inc - Rentabilitas dodolan miturut bathi resik|Margin dodolan resik INmune Bio Corporation INMB|Barinthus Biotherapeutics - Margin dodolan resik|Kezar Life Sciences, Inc. (KZR) - Rentabilitas dodolan miturut bathi resik|SAB Biotherapeutics Inc. (SABS) - Margin resik|Rentabilitas dodolan miturut bathi resik Akari Therapeutics plc|Margin resik enlivex.com|q32bio.com (QTTB) - Margin dodolan perusahaan|Margin dodolan resik GOVX|Edesa Biotech, Inc. - Rentabilitas dodolan resik|iBio Inc - Rentabilitas dodolan miturut bathi resik|Margin dodolan resik Carisma Therapeutics CARM|XTLB - Margin resik|BOLT (boltbio.com) - Rentabilitas dodolan resik|HCWB: Margin dodolan resik|Aptevo (APVO) - Margin dodolan resik|Margin resik AIM ImmunoTech|Rentabilitas dodolan miturut bathi resik Aditxt (ADTX)|Rentabilitas dodolan miturut bathi resik GRI (GRI Bio Corporation)|XORTX - Rentabilitas dodolan resik|Margin dodolan resik HIND (Vyome Holdings Inc.)|Tingkat bathi resik REVB|Indaptus - Margin dodolan resik|SCNI (Scinai Immunotherapeutics Ltd.) - Rentabilitas dodolan resik|CALI: Margin dodolan resik|Affimed NV - Tingkat bathi resik|Margin resik Allakos Inc.|Margin dodolan resik HOOKIPA Pharma|Margin resik IGM Biosciences, Inc. (IGMS)|ITOS - Margin resik|Margin dodolan resik OCEA (Ocean Bio)|Tingkat bathi resik TCBP